IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collins, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collins, F. M.
Infect Immun. 1971 December; 4(6): 688-696
Copyright © 1971 American Society for Microbiology. All Rights Reserved.

Immunogenicity of Various Mycobacteria and the Corresponding Levels of Cross-Protection Developed Between Species

F. M. Collins

1 Trudeau Institute, Saranac Lake, New York 12983

ABSTRACT

Seven mycobacterial species were tested for their ability to immunize mice against subsequent tuberculous challenge. The phylogenetic relationships between the vaccine and challenge strains had little direct influence on the level of resistance; a better correlation was found between the ability of the vaccine to survive or multiply in vivo and the immunogenicity of the organism. Mycobacterium tuberculosis, M. bovis (except for an SMR variant), M. avium, two of three M. kansasii strains, and one strain of M. intracellulare all survived or multiplied in vivo. They induced an effective resistance against a subsequent M. tuberculosis (Erdman) or BCG challenge. The SMR BCG, the Bostrom strain of M. kansasii, M. scrofulaceum, three strains of M. intracellulare, and one of M. terrae and M. fortuitum were unable to survive in vivo and were nonallergenic and nonimmunogenic. No evidence was found for an interference phenomenon between the atypical mycobacteria and the BCG vaccine sufficient to explain the inadequate levels of immunization reported in some field trials.


Infect Immun. 1971 December; 4(6): 688-696
Copyright © 1971 American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 1971 by the American Society for Microbiology. All rights reserved.